Biosckin, Molecular and Cell Therapies, S.A. is a Portuguese biotechnology and healthcare company founded in 2006. Its main activity is Cord Blood and Tissue Banking and its laboratory is authorized by the legal Healthcare authorities which regulate this activity. Ensuring all quality requirements and standards of excellence in the whole Banking process, Biosckin is specialized in analysis, processing, cryopreservation, storage and distribution of Umbilical Cord Blood and Cord Tissue. It also centers its activity on the development of cellular products combined with biomaterials, for future applications in Regenerative Medicine and Tissue Engineering. Focused on R&D, Biosckin has a solid multidisciplinary research network, with several national and international partnerships and collaborations.